Ledger.Open graph →
SEC Form D · filed January 5, 2016

Vertice Pharma UK Parent Ltd

Offering
$300.0M
Sold
$300.0M
Exemption
Rule 506(b)
Industry
Other
Location
Berkley Heights, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Arpad Szechenyi · Berkley Heights, NJExecRuoxi Chen · New York, NYDirectorRalph Landau · Berkley Heights, NJExecAnthony Woolf · London, United KingdomDirectorMarc Padre · Berkley Heights, NJExecDon Degolyer · Berkley Heights, NJExec · DirectorNoah Knauf · New York, NYDirectorAndrew Saik · Berkley Heights, NJExecGuruprasad Venkataramanan · Murphy, TXDirectorRalph Landau · Berkley Heights, NJExecNoah Knauf · New York, NYDirectorAndrew Saik · Berkley Heights, NJExecKevin H. Spain · Denver, COExecJames J. Sullivan · Denver, CODirectorLinda J. Fenton · Denver, COExec · DirectorStephen H. Kraus · Denver, COExecBulwarkBay Investment Group GP LLC · Boston, MAExecMichael Barakat · Houston, TXExec · DirectorMaurice Hochschild · San Mateo, CAExecEric Bertrand · Ta'xbiex, O1DirectorGabe Santos · SAN FRANCISCO, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗